Answers are grounded in this paper and cite their sources.
Although hepatic steatosis is associated with increased central obesity and insulin resistance, metabolic dysfunction per se rather than hepatic steatosis explains cardiovascular risk in these patients.
No takes yet. Share an insight, caveat, or question.
Semmler et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: